BerandaSCNI • NASDAQ
add
Scinai Immunotherapeutics Ltd - ADR
Tutup sebelumnya
$3,48
Rentang hari
$3,52 - $3,80
Rentang tahun
$2,34 - $8,92
Kapitalisasi pasar
3,01Â jt USD
Volume Rata-Rata
10,44Â rb
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 168,00 rb | — |
Biaya operasional | 2,17Â jt | 3,28% |
Laba bersih | 10,46Â jt | 236,50% |
Margin laba bersih | 6,22 rb | — |
Penghasilan per saham | — | — |
EBITDA | -1,92Â jt | 1,79% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,03Â jt | -83,78% |
Total aset | 12,26Â jt | -34,02% |
Total liabilitas | 2,26Â jt | -89,39% |
Total ekuitas | 10,00 jt | — |
Saham yang beredar | 853,00 rb | — |
Harga terhadap nilai buku | 0,30 | — |
Tingkat pengembalian aset | -44,63% | — |
Tingkat pengembalian modal | -48,85% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 10,46Â jt | 236,50% |
Kas dari operasi | -2,04Â jt | 8,28% |
Kas dari investasi | -4,00Â rb | 80,00% |
Kas dari pembiayaan | 8,00Â rb | -99,26% |
Perubahan kas bersih | -1,92Â jt | -67,45% |
Arus kas bebas | -2,48Â jt | -53,77% |
Tentang
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
Didirikan
1 Jan 2003
Situs
Karyawan
31
